Patient Research
Find a studySpecialtiesConditionsTreatmentsBy countryLearn
Sign in
All treatments
Treatment

BMS-986507, CISPLATIN, PEMETREXED, CARBOPLATIN, BL-B01D1, PEGFILGRASTIM clinical trials

1 indexed studies · 0 currently recruiting

  • AuthorisedPhase II and Phase III (Integrated)

    IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy

    This study is for people with a specific type of lung cancer that has stopped responding to treatment. Researchers are testing a new drug, Izalontamab Brengitecan, against standard chemotherapy to see which works better at controlling the cancer and helping people live longer.

    For: EGFR-mutated Non-small Cell Lung Cancer
    Poland · Germany · Italy
Advertisement
Advertisement
Advertisement
Patient.info Research

Find clinical research studies and trials explained in plain English - powered by Patient.info.

About
  • About us
  • Advertise with us
  • Partnerships
  • Authors
  • Contact us
Research explained
  • What is a clinical trial?
  • Trial phases explained
  • Why volunteer?
  • Clinical research FAQ
  • All health-research articles
Legal
  • About our content
  • Report a correction
  • Accessibility statement
  • Cookie policy
  • Privacy policy
  • Terms of use
  • Editorial policy
Find a study

Search clinical research studies and trials by condition, location and eligibility.

Browse studies →Learn about trials →
Information only. Research.Patient.info surfaces public clinical-trial registry data and explains it in plain English. We are not affiliated with the MHRA, HRA, NHS, NIHR or any regulator. Inclusion of a study is not an endorsement and is not medical advice — always discuss with your own doctor before agreeing to take part. See about our content or report a correction.
© 2026 Navigate Health Ltd. All rights reserved.
Registered number: 16229589
Registered office: 128 City Road, London, United Kingdom, EC1V 2NX.
Patient is a UK registered trade mark.
Patient does not provide medical advice, diagnosis or treatment.